Veeva Systems Inc. $VEEV Shares Sold by Jensen Investment Management Inc.

Jensen Investment Management Inc. lowered its stake in Veeva Systems Inc. (NYSE:VEEV) by 6.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,411 shares of the technology company’s stock after selling 1,440 shares during the quarter. Jensen Investment Management Inc.’s holdings in Veeva Systems were worth $5,878,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in VEEV. Sigma Planning Corp boosted its stake in Veeva Systems by 1.2% during the second quarter. Sigma Planning Corp now owns 3,328 shares of the technology company’s stock valued at $958,000 after buying an additional 39 shares in the last quarter. Keybank National Association OH raised its holdings in shares of Veeva Systems by 1.4% during the second quarter. Keybank National Association OH now owns 3,088 shares of the technology company’s stock valued at $889,000 after acquiring an additional 42 shares during the period. Facet Wealth Inc. lifted its holdings in shares of Veeva Systems by 3.3% in the second quarter. Facet Wealth Inc. now owns 1,342 shares of the technology company’s stock valued at $381,000 after purchasing an additional 43 shares in the last quarter. TFB Advisors LLC lifted its stake in Veeva Systems by 1.2% in the 1st quarter. TFB Advisors LLC now owns 3,586 shares of the technology company’s stock worth $831,000 after acquiring an additional 44 shares in the last quarter. Finally, Triangle Securities Wealth Management lifted its position in shares of Veeva Systems by 0.8% in the second quarter. Triangle Securities Wealth Management now owns 5,782 shares of the technology company’s stock worth $1,665,000 after purchasing an additional 45 shares in the last quarter. 88.20% of the stock is owned by institutional investors.

Insider Activity at Veeva Systems

In related news, insider Thomas D. Schwenger sold 3,350 shares of Veeva Systems stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the sale, the insider directly owned 23,773 shares in the company, valued at $7,132,850.92. This trade represents a 12.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jonathan Faddis sold 14,595 shares of Veeva Systems stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $300.00, for a total transaction of $4,378,500.00. Following the sale, the senior vice president owned 8,588 shares of the company’s stock, valued at approximately $2,576,400. This represents a 62.96% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 24,665 shares of company stock worth $7,438,000 over the last 90 days. Insiders own 10.30% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on VEEV. Weiss Ratings reissued a “hold (c+)” rating on shares of Veeva Systems in a research report on Wednesday, October 8th. Morgan Stanley upped their price objective on shares of Veeva Systems from $210.00 to $222.00 and gave the stock an “underweight” rating in a report on Thursday, August 28th. BTIG Research reaffirmed a “buy” rating and issued a $340.00 target price on shares of Veeva Systems in a report on Friday, October 17th. Evercore ISI raised their price target on shares of Veeva Systems from $285.00 to $295.00 and gave the stock an “in-line” rating in a research report on Thursday, August 28th. Finally, Wells Fargo & Company boosted their price objective on Veeva Systems from $300.00 to $326.00 and gave the company an “overweight” rating in a research report on Tuesday, August 26th. Seventeen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $307.28.

Veeva Systems Stock Performance

Shares of VEEV opened at $293.24 on Friday. The stock has a fifty day moving average price of $288.89 and a two-hundred day moving average price of $277.67. The company has a market cap of $48.06 billion, a price-to-earnings ratio of 60.21, a PEG ratio of 2.22 and a beta of 0.98. Veeva Systems Inc. has a 52-week low of $201.54 and a 52-week high of $310.50.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Wednesday, August 27th. The technology company reported $1.26 earnings per share for the quarter, missing the consensus estimate of $1.90 by ($0.64). Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The company had revenue of $789.08 million during the quarter, compared to analyst estimates of $768.49 million. During the same quarter in the previous year, the business posted $1.62 EPS. The company’s revenue was up 16.7% compared to the same quarter last year. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. As a group, research analysts predict that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.